HIGHLIGHTS
- who: Panu Wetwittayakhlang and collaborators from the Division of Gastroenterology, McGill University Health Center, Montreal, QC H G , Canada have published the Article: The Optimal Management of Fistulizing Crohnu2019s Disease: Evidence beyond Randomized Clinical Trials, in the Journal: (JOURNAL) of 25/05/2022
- what: This study showed that a higher proportion of patients receiving VDZ achieved fistula closure at week 52 compared to those who received the placebo (31% vs. 11%, absolute risk reduction 19.7%, 95% CI -8.9 to 46.2). This study showed an inferior outcome with respect to chronic seton treatment . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.